HC Wainwright restated their buy rating on shares of BiomX (NYSEMKT:PHGE – Free Report) in a research note issued to investors on Monday, Benzinga reports. They currently have a $2.00 price target on the stock.
BiomX Trading Up 1.8 %
NYSEMKT PHGE opened at $0.30 on Monday. The business’s fifty day simple moving average is $0.32 and its two-hundred day simple moving average is $0.31. The company has a current ratio of 2.84, a quick ratio of 2.84 and a debt-to-equity ratio of 0.51. The stock has a market cap of $16.30 million, a PE ratio of -0.56 and a beta of 1.36.
About BiomX
Featured Stories
- Five stocks we like better than BiomX
- Why Are Stock Sectors Important to Successful Investing?
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Pros And Cons Of Monthly Dividend Stocks
- Merger or Not, Albertson’s Companies is a Good Buy
- The Significance of Brokerage Rankings in Stock Selection
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.